Skip to main content
. Author manuscript; available in PMC: 2017 Feb 1.
Published in final edited form as: Gastroenterology. 2015 Oct 21;150(2):419–429. doi: 10.1053/j.gastro.2015.10.013

Figure 3.

Figure 3

Odds ratio estimates from logistic regression models of SVR12 and baseline factors for patients treated with simeprevir plus sofosbuvir with or without ribavirin.

Odds ratios are adjusted for regimen (+R v. −R), genotype (1a v. 1b), gender (male vs. female), and age. Each line represents a unique model. Observations are weighted with the inverse of probability of treatment weights (IPTW)

Population: patients which completed a full course of treatment or prematurely discontinued treatment for virological reasons.